Arch BioPartners
About Arch BioPartners
Arch BioPartners offers new products and technology for sale to pharmaceutical and industrial companies. The company provides treatments for brain tumors, chronic kidney and bowel diseases caused by non-infectious inflammation, and binding of peptides to solid surfaces. It is based in Toronto, Ontario.
Arch BioPartners Headquarter Location
27 St Clair Ave East
Toronto, Ontario, M4T 2M5,
Canada
Arch BioPartners Patents
Arch BioPartners has filed 1 patent.
The 3 most popular patent topics include:
- Clusters of differentiation
- Immune system
- Immunology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/2/2019 | 3/29/2022 | Clusters of differentiation, Immune system, Immunology, Transcription factors, Inflammations | Grant |
Application Date | 12/2/2019 |
|---|---|
Grant Date | 3/29/2022 |
Title | |
Related Topics | Clusters of differentiation, Immune system, Immunology, Transcription factors, Inflammations |
Status | Grant |
Latest Arch BioPartners News
Feb 15, 2022
The dosing with LSALT peptide in the CATCO trial is anticipated to start following final domestic approval and site preparation. The post Health Canada approves amendment to Arch Biopartners’ Covid-19 trial appeared first on Clinical Trials Arena.
Arch BioPartners Web Traffic
Arch BioPartners Rank
Where is Arch BioPartners's headquarters?
Arch BioPartners's headquarters is located at 27 St Clair Ave East, Toronto.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.